Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
PET Radiopharmaceuticals market report explains the definition, types, applications, major countries, and major players of the PET Radiopharmaceuticals market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Bracco Imaging SpA (Italy)
Mallinckrodt plc (Ireland)
Cardinal Health Inc (US)
Lantheus Medical Imaging, Inc (US)
Advanced Accelerator Applications SA (France)
Eczacibasi-Monrol Nuclear Products (Turkey)
IBA Molecular Imaging (Belgium)
Nordion, Inc (Canada)
GE Healthcare (UK)
Bayer AG (Germany)
By Type:
F-18
Ru-82
Others
By End-User:
Oncology
Cardiology
Neurology
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global PET Radiopharmaceuticals Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 PET Radiopharmaceuticals Outlook to 2028- Original Forecasts
-
2.2 PET Radiopharmaceuticals Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term PET Radiopharmaceuticals Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global PET Radiopharmaceuticals Market- Recent Developments
-
6.1 PET Radiopharmaceuticals Market News and Developments
-
6.2 PET Radiopharmaceuticals Market Deals Landscape
7 PET Radiopharmaceuticals Raw Materials and Cost Structure Analysis
-
7.1 PET Radiopharmaceuticals Key Raw Materials
-
7.2 PET Radiopharmaceuticals Price Trend of Key Raw Materials
-
7.3 PET Radiopharmaceuticals Key Suppliers of Raw Materials
-
7.4 PET Radiopharmaceuticals Market Concentration Rate of Raw Materials
-
7.5 PET Radiopharmaceuticals Cost Structure Analysis
-
7.5.1 PET Radiopharmaceuticals Raw Materials Analysis
-
7.5.2 PET Radiopharmaceuticals Labor Cost Analysis
-
7.5.3 PET Radiopharmaceuticals Manufacturing Expenses Analysis
8 Global PET Radiopharmaceuticals Import and Export Analysis (Top 10 Countries)
-
8.1 Global PET Radiopharmaceuticals Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global PET Radiopharmaceuticals Export by Region (Top 10 Countries) (2017-2028)
9 Global PET Radiopharmaceuticals Market Outlook by Types and Applications to 2022
-
9.1 Global PET Radiopharmaceuticals Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global F-18 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Ru-82 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global PET Radiopharmaceuticals Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Neurology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise PET Radiopharmaceuticals Market Analysis and Outlook till 2022
-
10.1 Global PET Radiopharmaceuticals Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States PET Radiopharmaceuticals Consumption (2017-2022)
-
10.2.2 Canada PET Radiopharmaceuticals Consumption (2017-2022)
-
10.2.3 Mexico PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3.2 UK PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3.3 Spain PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3.4 Belgium PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3.5 France PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3.6 Italy PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3.7 Denmark PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3.8 Finland PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3.9 Norway PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3.10 Sweden PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3.11 Poland PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3.12 Russia PET Radiopharmaceuticals Consumption (2017-2022)
-
10.3.13 Turkey PET Radiopharmaceuticals Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China PET Radiopharmaceuticals Consumption (2017-2022)
-
10.4.2 Japan PET Radiopharmaceuticals Consumption (2017-2022)
-
10.4.3 India PET Radiopharmaceuticals Consumption (2017-2022)
-
10.4.4 South Korea PET Radiopharmaceuticals Consumption (2017-2022)
-
10.4.5 Pakistan PET Radiopharmaceuticals Consumption (2017-2022)
-
10.4.6 Bangladesh PET Radiopharmaceuticals Consumption (2017-2022)
-
10.4.7 Indonesia PET Radiopharmaceuticals Consumption (2017-2022)
-
10.4.8 Thailand PET Radiopharmaceuticals Consumption (2017-2022)
-
10.4.9 Singapore PET Radiopharmaceuticals Consumption (2017-2022)
-
10.4.10 Malaysia PET Radiopharmaceuticals Consumption (2017-2022)
-
10.4.11 Philippines PET Radiopharmaceuticals Consumption (2017-2022)
-
10.4.12 Vietnam PET Radiopharmaceuticals Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil PET Radiopharmaceuticals Consumption (2017-2022)
-
10.5.2 Colombia PET Radiopharmaceuticals Consumption (2017-2022)
-
10.5.3 Chile PET Radiopharmaceuticals Consumption (2017-2022)
-
10.5.4 Argentina PET Radiopharmaceuticals Consumption (2017-2022)
-
10.5.5 Venezuela PET Radiopharmaceuticals Consumption (2017-2022)
-
10.5.6 Peru PET Radiopharmaceuticals Consumption (2017-2022)
-
10.5.7 Puerto Rico PET Radiopharmaceuticals Consumption (2017-2022)
-
10.5.8 Ecuador PET Radiopharmaceuticals Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain PET Radiopharmaceuticals Consumption (2017-2022)
-
10.6.2 Kuwait PET Radiopharmaceuticals Consumption (2017-2022)
-
10.6.3 Oman PET Radiopharmaceuticals Consumption (2017-2022)
-
10.6.4 Qatar PET Radiopharmaceuticals Consumption (2017-2022)
-
10.6.5 Saudi Arabia PET Radiopharmaceuticals Consumption (2017-2022)
-
10.6.6 United Arab Emirates PET Radiopharmaceuticals Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria PET Radiopharmaceuticals Consumption (2017-2022)
-
10.7.2 South Africa PET Radiopharmaceuticals Consumption (2017-2022)
-
10.7.3 Egypt PET Radiopharmaceuticals Consumption (2017-2022)
-
10.7.4 Algeria PET Radiopharmaceuticals Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia PET Radiopharmaceuticals Consumption (2017-2022)
-
10.8.2 New Zealand PET Radiopharmaceuticals Consumption (2017-2022)
11 Global PET Radiopharmaceuticals Competitive Analysis
-
11.1 Bracco Imaging SpA (Italy)
-
11.1.1 Bracco Imaging SpA (Italy) Company Details
-
11.1.2 Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Main Business and Markets Served
-
11.1.4 Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Mallinckrodt plc (Ireland)
-
11.2.1 Mallinckrodt plc (Ireland) Company Details
-
11.2.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Main Business and Markets Served
-
11.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Cardinal Health Inc (US)
-
11.3.1 Cardinal Health Inc (US) Company Details
-
11.3.2 Cardinal Health Inc (US) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Cardinal Health Inc (US) PET Radiopharmaceuticals Main Business and Markets Served
-
11.3.4 Cardinal Health Inc (US) PET Radiopharmaceuticals Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Lantheus Medical Imaging, Inc (US)
-
11.4.1 Lantheus Medical Imaging, Inc (US) Company Details
-
11.4.2 Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Main Business and Markets Served
-
11.4.4 Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Advanced Accelerator Applications SA (France)
-
11.5.1 Advanced Accelerator Applications SA (France) Company Details
-
11.5.2 Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Main Business and Markets Served
-
11.5.4 Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Eczacibasi-Monrol Nuclear Products (Turkey)
-
11.6.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Details
-
11.6.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Main Business and Markets Served
-
11.6.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 IBA Molecular Imaging (Belgium)
-
11.7.1 IBA Molecular Imaging (Belgium) Company Details
-
11.7.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Main Business and Markets Served
-
11.7.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Nordion, Inc (Canada)
-
11.8.1 Nordion, Inc (Canada) Company Details
-
11.8.2 Nordion, Inc (Canada) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Nordion, Inc (Canada) PET Radiopharmaceuticals Main Business and Markets Served
-
11.8.4 Nordion, Inc (Canada) PET Radiopharmaceuticals Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 GE Healthcare (UK)
-
11.9.1 GE Healthcare (UK) Company Details
-
11.9.2 GE Healthcare (UK) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 GE Healthcare (UK) PET Radiopharmaceuticals Main Business and Markets Served
-
11.9.4 GE Healthcare (UK) PET Radiopharmaceuticals Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Bayer AG (Germany)
-
11.10.1 Bayer AG (Germany) Company Details
-
11.10.2 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Bayer AG (Germany) PET Radiopharmaceuticals Main Business and Markets Served
-
11.10.4 Bayer AG (Germany) PET Radiopharmaceuticals Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global PET Radiopharmaceuticals Market Outlook by Types and Applications to 2028
-
12.1 Global PET Radiopharmaceuticals Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global F-18 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Ru-82 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global PET Radiopharmaceuticals Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Neurology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise PET Radiopharmaceuticals Market Analysis and Outlook to 2028
-
13.1 Global PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.2.2 Canada PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.2.3 Mexico PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3.2 UK PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3.3 Spain PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3.4 Belgium PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3.5 France PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3.6 Italy PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3.7 Denmark PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3.8 Finland PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3.9 Norway PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3.10 Sweden PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3.11 Poland PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3.12 Russia PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.3.13 Turkey PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.4.2 Japan PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.4.3 India PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.4.4 South Korea PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.4.5 Pakistan PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.4.7 Indonesia PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.4.8 Thailand PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.4.9 Singapore PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.4.10 Malaysia PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.4.11 Philippines PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.4.12 Vietnam PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.5.2 Colombia PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.5.3 Chile PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.5.4 Argentina PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.5.5 Venezuela PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.5.6 Peru PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.5.8 Ecuador PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.6.2 Kuwait PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.6.3 Oman PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.6.4 Qatar PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.7.2 South Africa PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.7.3 Egypt PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.7.4 Algeria PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia PET Radiopharmaceuticals Consumption Forecast (2022-2028)
-
13.8.2 New Zealand PET Radiopharmaceuticals Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of PET Radiopharmaceuticals
-
Figure of PET Radiopharmaceuticals Picture
-
Table Global PET Radiopharmaceuticals Import by Region (Top 10 Countries) (2017-2028)
-
Table Global PET Radiopharmaceuticals Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global F-18 Consumption and Growth Rate (2017-2022)
-
Figure Global Ru-82 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiology Consumption and Growth Rate (2017-2022)
-
Figure Global Neurology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global PET Radiopharmaceuticals Consumption by Country (2017-2022)
-
Table North America PET Radiopharmaceuticals Consumption by Country (2017-2022)
-
Figure United States PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Canada PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Mexico PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table Europe PET Radiopharmaceuticals Consumption by Country (2017-2022)
-
Figure Germany PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure UK PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Spain PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Belgium PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure France PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Italy PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Denmark PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Finland PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Norway PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Sweden PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Poland PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Russia PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Turkey PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table APAC PET Radiopharmaceuticals Consumption by Country (2017-2022)
-
Figure China PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Japan PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure India PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure South Korea PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Pakistan PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Indonesia PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Thailand PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Singapore PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Malaysia PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Philippines PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Vietnam PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table South America PET Radiopharmaceuticals Consumption by Country (2017-2022)
-
Figure Brazil PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Colombia PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Chile PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Argentina PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Venezuela PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Peru PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Ecuador PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table GCC PET Radiopharmaceuticals Consumption by Country (2017-2022)
-
Figure Bahrain PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Kuwait PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Oman PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Qatar PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table Africa PET Radiopharmaceuticals Consumption by Country (2017-2022)
-
Figure Nigeria PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure South Africa PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Egypt PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Algeria PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table Oceania PET Radiopharmaceuticals Consumption by Country (2017-2022)
-
Figure Australia PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure New Zealand PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table Bracco Imaging SpA (Italy) Company Details
-
Table Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Main Business and Markets Served
-
Table Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Product Portfolio
-
Table Mallinckrodt plc (Ireland) Company Details
-
Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Main Business and Markets Served
-
Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Portfolio
-
Table Cardinal Health Inc (US) Company Details
-
Table Cardinal Health Inc (US) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardinal Health Inc (US) PET Radiopharmaceuticals Main Business and Markets Served
-
Table Cardinal Health Inc (US) PET Radiopharmaceuticals Product Portfolio
-
Table Lantheus Medical Imaging, Inc (US) Company Details
-
Table Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Main Business and Markets Served
-
Table Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Product Portfolio
-
Table Advanced Accelerator Applications SA (France) Company Details
-
Table Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Main Business and Markets Served
-
Table Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Product Portfolio
-
Table Eczacibasi-Monrol Nuclear Products (Turkey) Company Details
-
Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Main Business and Markets Served
-
Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Portfolio
-
Table IBA Molecular Imaging (Belgium) Company Details
-
Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Main Business and Markets Served
-
Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Portfolio
-
Table Nordion, Inc (Canada) Company Details
-
Table Nordion, Inc (Canada) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nordion, Inc (Canada) PET Radiopharmaceuticals Main Business and Markets Served
-
Table Nordion, Inc (Canada) PET Radiopharmaceuticals Product Portfolio
-
Table GE Healthcare (UK) Company Details
-
Table GE Healthcare (UK) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare (UK) PET Radiopharmaceuticals Main Business and Markets Served
-
Table GE Healthcare (UK) PET Radiopharmaceuticals Product Portfolio
-
Table Bayer AG (Germany) Company Details
-
Table Bayer AG (Germany) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG (Germany) PET Radiopharmaceuticals Main Business and Markets Served
-
Table Bayer AG (Germany) PET Radiopharmaceuticals Product Portfolio
-
Figure Global F-18 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ru-82 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PET Radiopharmaceuticals Consumption Forecast by Country (2022-2028)
-
Table North America PET Radiopharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure United States PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe PET Radiopharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure Germany PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure France PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC PET Radiopharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure China PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure India PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Table South America PET Radiopharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure Brazil PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC PET Radiopharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure Bahrain PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa PET Radiopharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure Nigeria PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania PET Radiopharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure Australia PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
